Biological Products, Except Diagnostic Substances (Biotech) - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Biological industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Biological Products, Except Diagnostic Substances (Biotech) - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Biological Products, Except Diagnostic Substances (Biotech)
Corporate Insider Buy Sell Ratio (Insider Count) - Biological Products, Except Diagnostic Substances (Biotech)
Biological Products, Except Diagnostic Substances (Biotech) - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-04-23 TWST / Twist Bioscience Corporation 4 Finn Patrick John S - Sale D 60.761 -2,321
2026-04-23 IMVT / Immunovant, Inc. 4 Stout Jay S S - Sale D 29.62 -2,754
2026-04-23 SRRK / Scholar Rock Holding Corporation 4 Burow Kristina M - Exercise D 26.78 7,800
2026-04-23 SRRK / Scholar Rock Holding Corporation 4 Burow Kristina M - Exercise D 4.75 28,000
2026-04-23 SRRK / Scholar Rock Holding Corporation 4 Burow Kristina M - Exercise D 9.11 36,000
2026-04-23 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,722
2026-04-23 SRRK / Scholar Rock Holding Corporation 4 Burow Kristina M - Exercise D 8.36 18,000
2026-04-23 VXRT / Vaxart, Inc. 4 BREITMEYER JAMES B A - Award D 78,800
2026-04-22 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher S - Sale D 3.61 -40,000
2026-04-22 BNTX / BioNTech SE - Depositary Receipt (Common Stock) 4 Poetting Sierk S - Sale I 110.5592 -50,000
2026-04-22 SGMO / Sangamo Therapeutics, Inc. 4 Davis Gregory D S - Sale D 0.2534 -69,827
2026-04-22 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 15.77 -165,150
2026-04-22 TWST / Twist Bioscience Corporation 4 Leproust Emily M. S - Sale D 65.275 -7,910
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Chadwick Jeremy G S - Sale D 90 -300
2026-04-22 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.13 -19,060
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Booth Bruce S - Sale I 90.08 -88
2026-04-22 TWST / Twist Bioscience Corporation 4 Leproust Emily M. S - Sale D 66.00 -151
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Booth Bruce S - Sale I 90.08 -12
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Booth Bruce S - Sale D 89.96 -5,900
2026-04-22 TWST / Twist Bioscience Corporation 4 Leproust Emily M. M - Exercise D 8.82 8,061
2026-04-22 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,722
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Booth Bruce M - Exercise D 20 259
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Chadwick Jeremy G M - Exercise D 30.17 100
2026-04-22 TECH / Bio-Techne Corporation 4 Kelderman Kim M - Exercise D 11,344
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Chadwick Jeremy G M - Exercise D 43.5 200
2026-04-22 KYMR / Kymera Therapeutics, Inc. 4 Booth Bruce M - Exercise D 14.18 5,641
2026-04-22 TECH / Bio-Techne Corporation 4 Hippel James M - Exercise D 62,000
2026-04-22 TECH / Bio-Techne Corporation 4 Kelderman Kim F - Taxes D 58.58 -1,363
2026-04-22 TECH / Bio-Techne Corporation 4 Hippel James F - Taxes D 58.58 -56,097
2026-04-22 RXRX / Recursion Pharmaceuticals, Inc. 4 Gibson Christopher C - Conversion D 40,000
2026-04-21 RGEN / Repligen Corporation 4 Loeillot Olivier S - Sale D 140.00 -3,832
2026-04-21 TWST / Twist Bioscience Corporation 4 Leproust Emily M. S - Sale D 65.01 -1,610
2026-04-21 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.66 -30,941
2026-04-21 MGTX / MeiraGTx Holdings plc 4 Giroux Richard S - Sale D 10.22 -56,000
2026-04-21 SGMO / Sangamo Therapeutics, Inc. 4 Dubois-Stringfellow Nathalie S - Sale D 0.2578 -345,942
2026-04-21 ALLO / Allogene Therapeutics, Inc. 4 Yoshiyama Annie S - Sale D 2.31 -9,586
2026-04-21 BCDA / BioCardia, Inc. 4 Altman Peter P - Purchase D 1.23 400
2026-04-21 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 12.14 11,881
2026-04-21 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,722
2026-04-21 TWST / Twist Bioscience Corporation 4 Leproust Emily M. M - Exercise D 8.82 1,610
2026-04-20 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.55 -19,060
2026-04-20 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 15.77 -171,963
2026-04-20 BCDA / BioCardia, Inc. 4 Altman Peter P - Purchase D 1.23 600
2026-04-20 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE M - Exercise D 8.46 14,722
2026-04-20 FATE / Fate Therapeutics, Inc. 4 Redmile Group, LLC See Footnotes J - Other I 8,977,624
2026-04-20 FATE / Fate Therapeutics, Inc. 4 Redmile Group, LLC J - Other D -8,977,624
2026-04-17 TWST / Twist Bioscience Corporation 4 Laponis Adam S - Sale D 60 -4,000
2026-04-17 VOR / Vor Biopharma Inc. 4 RA CAPITAL MANAGEMENT, LLC See footnotes S - Sale I 16.28 -458,411
2026-04-17 ADPT / Adaptive Biotechnologies Corporation 4 RUBINSTEIN JULIE S - Sale D 14.57 -19,060
2026-04-17 CGON / CG Oncology, Inc. 4 Mulay James S - Sale D 73.01 -15,600
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)